Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03017781 · ClinicalTrials.gov registry record
A Study of the Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolar Disorder
A clinical trial of Bipolar Disorder, sponsored by Janssen Research & Development.
- Completed
- Registry status
- 224
- Enrollment target
- 20
- Study locations
NCT03017781 is a study of Bipolar Disorder that has completed, run by Janssen Research & Development. The registered enrollment target is 224 participants, below the 331-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (32% lower). The trial reports 20 study locations across 11 states.
The verdict
NCT03017781, a study of Bipolar Disorder, has completed, sponsored by Janssen Research & Development.
- COMPLETED
- Registry status
- 224 participants
- Enrollment target
- 20
- Study locations
Study Summary
The primary purpose of this study is to compare, over 24 months, the time spent with clinically significant mood symptoms (ie, mania, depression), as measured by the Longitudinal Interval Follow-Up Evaluation (LIFE) and the Psychiatric Status Rating Scale (PSR), in offspring of bipolar parents with and without at least mild impairment in psychosocial functioning.
Conditions Studied
Study Locations (20)
California
- - Culver City
- - Lemon Grove
- - Los Angeles
- - Palo Alto
- - Panorama City
Ohio
- - Cincinnati
- - Cleveland
- - Columbus
Texas
- - Austin
- - Dallas
- - El Paso
New York
- - Glen Oaks
- - Rochester
Florida
- - Tampa
Indiana
- - Indianapolis
Maryland
- - Baltimore
Massachusetts
- - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 224 participants |
| Start Date | 2016-10-25 |
| Est. Completion | 2021-04-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03017781
The ClinicalTrials.gov registry entry for NCT03017781 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 224 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 331-participant average among 162 other Bipolar Disorder trials with a reported enrollment target (32% lower). The listed sponsor is Janssen Research & Development, which has 593 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Bipolar Disorder appearing as the primary indexed condition, and to 0 interventions.
NCT03017781 reports 20 study locations spanning 11 distinct geographic areas - top geographies include California, Ohio, Texas.
Frequently Asked Questions
What is clinical trial NCT03017781 about?
NCT03017781 is a clinical study titled "A Study of the Relationship of Psychosocial Function With Mood Symptoms in Offspring of Parents With Bipolar Disorder". The primary purpose of this study is to compare, over 24 months, the time spent with clinically significant mood symptoms (ie, mania, depression), as measured by the Longitudinal Interval Follow-Up Evaluation (LIFE) and the Psychiatric Status Rating Scale (PSR), in offspring of bipolar parents with ...
What is the current status of trial NCT03017781?
This trial is currently completed. The enrollment target is 224 participants. The study started on 2016-10-25. Estimated completion is 2021-04-30.
What conditions does trial NCT03017781 study?
This clinical trial studies the following conditions: Bipolar Disorder.
Who is sponsoring clinical trial NCT03017781?
This trial is sponsored by Janssen Research & Development, which has 593 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03017781 being conducted?
This trial has 20 study locations across California, Florida, Indiana, Maryland, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Bipolar Disorder
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Taking Action for College Students
RECRUITING · NA
-
A Study to Evaluate the Efficacy and Safety of Adjunctive KarXT for the Treatment of Mania, With or Without Mixed Features, in Participants With Bipolar-I Disorder Taking Lithium, Valproate, or Lamotrigine
RECRUITING · Phase 3
-
Getting Out of the House: Using Behavioral Activation to Increase Community Participation
RECRUITING · NA
-
Assessing the Impact of Cannabidiol for Anxiety and Depression in Bipolar Disorder
RECRUITING · Phase 2
-
Correcting Circadian Rhythms to Breakthrough in Bipolar Disorder
RECRUITING · Phase 2
-
A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
RECRUITING · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.